Evidence map›Paper›PMID 37762669›Full record

ReviewInternational journal of molecular sciences2023

Therapeutic Effects of Curcumin Derivatives against Obesity and Associated Metabolic Complications: A Review of In Vitro and In Vivo Studies.

Marakiya T Moetlediwa, Rudzani Ramashia, Carmen Pheiffer, Salam J J Titinchi, Sithandiwe E Mazibuko-Mbeje, Babalwa U Jack

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Palmitoylethanolamide in Human and Animal Obesity.Molecules (Basel, Switzerland) · 2026
    Review
  3. Chemical constituents in the rhizome of Curcuma longa and the pharmacological importance of curcumin hybrids.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. The PI3K/Akt pathway: a target for curcumin's therapeutic effects.Journal of diabetes and metabolic disorders · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Modulatory Effects ofJournal of agricultural and food chemistry · 2024
    Article
  16. Obesity-Associated Colorectal Cancer.International journal of molecular sciences · 2024
    Review
  17. Structural Variances in Curcumin Degradants: Impact on Obesity in Mice.Journal of agricultural and food chemistry · 2024
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marakiya T MoetlediwaBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.
Rudzani RamashiaBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.
Carmen PheifferBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.ORCID 0000-0002-0707-1552
Salam J J TitinchiDepartment of Chemistry, Faculty of Natural Science, University of the Western Cape, Bellville 7535, South Africa.ORCID 0000-0002-5785-5021
Sithandiwe E Mazibuko-MbejeDepartment of Biochemistry, North-West University, Mmabatho 2745, South Africa.
Babalwa U JackBiomedical Research and Innovation Platform, South African Medical Research Council, Cape Town 7505, South Africa.ORCID 0000-0002-5716-9064
South African Medical Research Council · ZANorth-West University · ZAUniversity of the Western Cape · ZA

Funding

National Research Foundation Thuthuka Programme (Grant number: 129508)South African Medical Research Council Base line funding
6 · The paper itself

Abstract

Obesity is a major cause of morbidity and mortality globally, increasing the risk for chronic diseases. Thus, the need to identify more effective anti-obesity agents has spurred significant interest in the health-promoting properties of natural compounds. Of these, curcumin, the most abundant and bioactive constituent of turmeric, possesses a variety of health benefits including anti-obesity effects. However, despite its anti-obesity potential, curcumin has demonstrated poor bioavailability, which limits its clinical applicability. Synthesizing curcumin derivatives, which are structurally modified analogs of curcumin, has been postulated to improve bioavailability while maintaining therapeutic efficacy. This review summarizes in vitro and in vivo studies that assessed the effects of curcumin derivatives against obesity and its associated metabolic complications. We identified eight synthetic curcumin derivatives that were shown to ameliorate obesity and metabolic dysfunction in diet-induced obese animal models, while five of these derivatives also attenuated obesity and associated metabolic complications in cell culture models. These curcumin derivatives modulated adipogenesis, lipid metabolism, insulin resistance, steatosis, lipotoxicity, inflammation, oxidative stress, endoplasmic reticulum stress, apoptosis, autophagy, fibrosis, and dyslipidemia to a greater extent than curcumin. In conclusion, the findings from this review show that compared to curcumin, synthetic curcumin derivatives present potential candidates for further development as therapeutic agents to modulate obesity and obesity-associated metabolic complications.

Indexed as

CurcuminAnimalsApoptosisLipid MetabolismObesityOxidative StressCurcumincurcumincurcumin derivativescurcuminoidsobesityobesity-associated complicationssynthetic compounds

Identifiers

PMID37762669
PMCPMC10531575
OpenAlexW4386934586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.